Steroid-Resistant Bullous Pemphigoid After Leuprolide Acetate Exposure in a Patient With Multiple Sclerosis

• November 3, 2026

Reading Skin Cancer’s Molecular Fingerprint

Machine-learning models analyzed Raman spectra to distinguish cancerous tissue from normal skin

• October 13, 2026

• 3 min

Exploring How Healthcare Professionals Diagnose and Manage Vitiligo: Global VALIANT Study Findings and Recommendations

• by Khaled Ezzedine, John E. Harris, Iltefat H. Hamzavi, Nanja van Geel, Kristen Bibeau, Jessy Gao, Haobo Ren, Pearl Grimes

• October 28, 2026

FDA approves pritelivir for refractory HSV lesions

In a phase 3 trial, complete lesion healing occurred in 63% of patients receiving pritelivir vs. 34% receiving comparator treatments.

• by Teraya Smith

• October 9, 2026

• 2 min